Lonza Upgrades Live-Cell Imaging System
For Obtaining Better Cell-Culture Analyses
Antibody Characterization Balances Rigor and Reason
Emphasizes a Combination of Antibody-Dependent and -Independent Testing Methods
Cancer Immunotherapy Spurs Work on Better Animal Models
GEN Spoke to Several Researchers on Advances in Engineered Animal Models Used to Study Novel Cancer Im-munotherapies
The Rise of Single-Cell Genomics
The Ability to Profile Single Whole Cells and Single Nuclei Will Also Help Shape Understanding of Each Cell Type
Search Results for
Top 10 Wall Street Winners of 2016
February 6, 2017
jumping nearly 116% before announcing on January 9 that it is being acquired by Takeda Pharmaceutical for approximately $5.2 billion. #10. Argos Therapeutics NASDAQ: ARGS ...
Takeda, Ovid to Co-Develop Rare Pediatric Epilepsy Candidate...
January 18, 2017
GEN News Highlights More » January 18, 2017 Takeda, Ovid to Co-Develop Rare Pediatric Epilepsy Candidate TAK-935 Takeda Pharmaceutical said its rare pediatric epilepsy candidate ...
Takeda to Acquire Ariad Pharmaceuticals for $5.2B
January 9, 2017
GEN News Highlights More » January 9, 2017 Takeda to Acquire Ariad Pharmaceuticals for $5.2B Ariad Pharmaceuticals has agreed to be acquired by Takeda Pharmaceutical for ...
10 Takeover Targets of 2016
October 24, 2016
... Needham has cited Teva among 11 potential suitors for Acadia, a list that included AstraZeneca, Allergan, Eli Lilly, Lundbeck, Merck, Novartis, and Takeda Pharmaceutical. Alexion ...
Moderna Wins Up to $125M from BARDA toward Zika mRNA Vaccine...
September 7, 2016
The award is the second potentially nine-figure BARDA contract awarded in less than a week toward Zika vaccine development. On Thursday, Takeda Pharmaceutical announced an award of ...
BARDA Awards Takeda Up to $312M toward Zika Vaccine
September 1, 2016
GEN News Highlights More » September 1, 2016 BARDA Awards Takeda Up to $312M toward Zika Vaccine Takeda Pharmaceutical said it will receive up to $312 million from the Biomedical ...
Cluster's Mass. Appeal Draws Companies, Jobs
August 16, 2016
while Pfizer broke ground on a $200 million biologics clinical manufacturing facility in Andover, MA. Merck & Co. and Takeda Pharmaceutical said they will expand R&D in Cambridge. ...
Top 10 U.S. Biopharma Clusters
May 2, 2016
... Abbott, Baxter International, and their respective spinouts AbbVie and Baxalta, anchor the region, as do the U.S. headquarters of both Astellas and Takeda. #9. Los Angeles / Orange ...
15 Top-Selling Drugs Launched in 2015
March 7, 2016
The eight were Praluent® (Sanofi/Regeneron), Afrezza® (MannKind and, until January, Sanofi), Aristada(tm) (Alkermes), Ninlaro® (Millennium: The Takeda Oncology Company), ...
Takeda, Mersana Expand ADC Collaboration
February 3, 2016
GEN News Highlights More » February 3, 2016 Takeda, Mersana Expand ADC Collaboration Mersana Therapeutics has granted Takeda Pharmaceutical rights to its lead product candidate, ...